Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Lilly snaps up autoimmune drug in $400m biotech partnership

July 25, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma

Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …
News
erard_gilles

Context Therapeutics add new CMO

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Context Therapeutics, biotech, drugs, pharma, pharmaceutical

Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …
Appointment

NHS England takes tough stance on homeopathy

July 24, 2017 Sales and Marketing NHS England, biotech, drugs, pharma, pharmaceutical

Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …
News

Wave expands editorial and programme delivery teams with two appointments

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, pharma, pharmaceutical

Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …
Appointment
british_pharmacopeia

The British Pharmacopoeia 2018 now available

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Pharmacopoeia, biotech, drugs, healthcare, pharma, pharmaceutical

The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …
Feature

Monthly injectable HIV treatment proves as effective as traditional daily pill regimen

July 24, 2017 Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals

New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
News
pills_in_pot

Over 3% of all drugs in Indian market not up to standard

July 24, 2017 Manufacturing and Production, Sales and Marketing India, biotech, drugs, pharma, pharmaceutical

The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that …
News
teva_copy

Teva to cut over 300 production jobs in Israel

July 24, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical

Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …
News
neuroderm_product

$1.1 billion swoop for promising Parkinson’s drug developer

July 24, 2017 Sales and Marketing Mitsubishi Tanabe Pharma Corporation, Neuroderm, biotech, drugs, pharma, pharmaceutical

Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that it has moved to acquire Israeli pharma company, NeuroDerm, in a deal …
News
laurie-glimcher-large

GSK unveil appointment coup for board of directors

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, GSK, biotech, drugs, immunooncology, pharma, pharmaceutical

GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
News
white_house_trump

Trump throws weight behind pharmaceutical manufacturing

July 21, 2017 Medical Communications, Sales and Marketing FDA, President trump, Trump, biotech, drugs, pharma, pharmaceutical

In a press conference at the White House, President Trump, alongside representatives from Corning, MSD and Pfizer, announced that 1,000 …
News
merck_and_co

MSD’s Lantus biosimilar given conditional FDA approval

July 21, 2017 Medical Communications, Sales and Marketing FDA, MSD, Sanofi, biosimilar, biotech, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …
News
dr-nathan-brown

BenevolentAI installs new Head of Cheminformatics

July 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

BenevolentAI, a company that uses an artificial intelligence platform to improve drug discovery, has announced the appointment of Nathan Brown …
Appointment
595427

Leo Pharma gets European approval for unique plaque psoriasis drug

July 20, 2017 Sales and Marketing EU, European Commission, biotech, drugs, pharma, pharmaceutical, psoriasis

The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026